---
figid: PMC6109480__JIR2018-6984948.001
figtitle: PD-1/PD-L1 signaling and reprograming in T cells
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6109480
filename: JIR2018-6984948.001.jpg
figlink: /pmc/articles/PMC6109480/figure/fig1/
number: F1
caption: 'Effect of PD-1/PD-L1 signaling on major signaling pathways and reprograming
  in T cells. Upon the stimulation of antigen, the MHC on the surface of APC could
  present antigens to the TCR and promote TCR/CD3 chains to phosphorylate, resulting
  in an activation and recruitment of Lck and Zap-70, which in turn lead to the phosphorylation
  of tyrosine motifs (ITAM) and initiation of the downstream signaling cascade of
  TCR. However, in the pathological state, the PD-1 bind to its ligand PD-L1 or PD-L2;
  the tyrosine phosphatase SHP-2 or SHP-1 can be recruited and bind to the ITSM sequence
  in the PD-1 cytoplasmic tail. An activation of PD-L/PD-L1 signaling PD-1 mediates
  the inhibition of the PI3K/Akt and Ras/MEK/Erk signaling pathway, resulting in the
  inhibition of T cell proliferation, protein synthesis, survival, and IL-2 production.
  APC: antigen-presenting cell; HLA: human leukocyte antigen; TCR: T cell receptor.'
papertitle: 'Anti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized
  Medicine and Combination Strategies.'
reftext: Hongshu Sui, et al. J Immunol Res. 2018;2018:6984948.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9293209
figid_alias: PMC6109480__F1
figtype: Figure
redirect_from: /figures/PMC6109480__F1
ndex: 71b03968-df0b-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6109480__JIR2018-6984948.001.html
  '@type': Dataset
  description: 'Effect of PD-1/PD-L1 signaling on major signaling pathways and reprograming
    in T cells. Upon the stimulation of antigen, the MHC on the surface of APC could
    present antigens to the TCR and promote TCR/CD3 chains to phosphorylate, resulting
    in an activation and recruitment of Lck and Zap-70, which in turn lead to the
    phosphorylation of tyrosine motifs (ITAM) and initiation of the downstream signaling
    cascade of TCR. However, in the pathological state, the PD-1 bind to its ligand
    PD-L1 or PD-L2; the tyrosine phosphatase SHP-2 or SHP-1 can be recruited and bind
    to the ITSM sequence in the PD-1 cytoplasmic tail. An activation of PD-L/PD-L1
    signaling PD-1 mediates the inhibition of the PI3K/Akt and Ras/MEK/Erk signaling
    pathway, resulting in the inhibition of T cell proliferation, protein synthesis,
    survival, and IL-2 production. APC: antigen-presenting cell; HLA: human leukocyte
    antigen; TCR: T cell receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - csw
  - pd
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
  - CkIIbeta
  - CkIIbeta2
  - CkIIalpha
  - ten
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Lk
  - et
  - Orc3
  - rl
  - Gad1
  - Mtor
  - Tor
  - NFAT
  - bel
  - Gip
  - ras
  - Ras64B
  - Ras85D
  - Pten
  - Dsor1
  - Mtk
  - step
  - PTPN11
  - PTPN6
  - APC
  - PROC
  - CSNK2A1
  - CSNK2A2
  - CSNK2B
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - LCK
  - LAT
  - ORC3
  - SPNS1
  - MAPK3
  - MAPK1
  - GRAP2
  - LCP2
  - MTOR
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - GIP
  - GNAI2
  - C1QTNF1
  - KRAS
  - HRAS
  - NRAS
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - RASGRP1
  - IL2
  - ZAP70
  - PTEN
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTG1
  - CYTH3
  - GDP
  - Cancer
  - Lung cancer
---
